Login
|
Register
News
Media
Insights
Peer Exchange
OncNurse TV
Webinars
Podcasts
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Register now to learn about a new option for relapsed or refractory follicular lymphoma
Blood Cancers
Acalabrutinib Poses Low Cardiac Risk in CLL, Analysis Shows
BY HAYLEY VIRGIL
Azacitidine Improves Survival Outcomes, Quality of Life in AML
BY NICHOLE TUCKER
Quality of Life Improves Over Time for Patients With Aggressive Lymphomas
BY BRIELLE BENYON
Nurses, Patients Prefer Subcutaneous Rituximab Over IV
BY BRIELLE BENYON
CAR T-Cell Therapy Improves Blood Cancer, But Toxicities Are Still Concerning
BY ERICA DINAPOLI
A Rundown of New Infusion Therapies
BY BRIELLE BENYON
Promising Response Rates Build Excitement for CAR T-Cell Therapy in Myeloma
BY JESSICA HERGERT
Off-the-Shelf CAR T-Cell Product CTX100 Promising in Relapsed/Refractory CD19+ B-Cell Malignancies
BY GINA MAURO
Brexucabtagene Autoleucel Approval Changes MCL Treatment Landscape
BY GINA MAURO
Is Chemotherapy an Emergency When Fertility Is at Risk?
BY STEPHANIE L. JACKSON, MSN, RN, AOCNS, BMTCN
<< Prev Page
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.